-

Dante Genomics to Launch Generative AI Features in Dante Labs Whole Genome Platform

Leading Genomics Information Company brings new innovation to genomics interpretation and consultation, in its mission to enhance the utility of the genome

NEW YORK--(BUSINESS WIRE)--Dante Genomics, a global leader in genomics and personalized medicine, announced today that it will begin integrating Generative AI features into its first product, the Dante Labs Whole Genome platform. This milestone represents a significant step forward in the company’s mission to make genomic data more actionable and accessible for both researchers and individuals.

"Generative AI cannot be a black box in genomics and diagnostics," said Andrea Riposati, CEO and co-founder of Dante Genomics. "We are taking the approach of autopilots on airplanes, supporting the human pilot to make important more informed decisions."

The integration of Generative AI is the result of months of rigorous development and testing, ensuring that the technology meets the highest standards of accuracy and reliability in genomic interpretation. The initiative aligns with Dante Genomics' broader vision to provide scalable, user-friendly tools for decoding the complexities of the human genome.

A Generative AI Revolution in Genomics

The new Generative AI features are designed to transform the way genomic data is interpreted:

  • Interactive Features: ability to explore the genome with interactive features.
  • Advanced Data Processing: Generative AI significantly reduces processing times, delivering actionable insights in record time.
  • Personalized Insights: Users will benefit from AI-powered narrative reports that make complex genomic information understandable and meaningful.
  • Medical Database: The AI integration supports diagnostic accuracy by identifying patterns not possible with traditional methods.
  • Scalable Innovation: Designed to meet the needs of individuals, researchers, and healthcare providers, the platform’s AI tools adapt to diverse use cases.

Commitment to Quality and Impact

This announcement builds on Dante Genomics' history of excellence in genomics. The company remains steadfast in its commitment to quality, having achieved multiple certifications for its technologies and adhering to stringent international standards. The Generative AI integration reflects the company’s continued investment in technologies that make a tangible difference in people’s lives.

The updated Dante Labs Whole Genome platform with Generative AI features will be available globally starting Q1 2025, with early access offered to select customers.

Contacts

Laura Rossi
media@dantelabs.com
+39 0862 191 0671

DANTE OMICS

Details
Headquarters: New York, USA
CEO: Andrea Riposati
Employees: 42
Organization: PRI

Release Versions

Contacts

Laura Rossi
media@dantelabs.com
+39 0862 191 0671

Social Media Profiles
More News From DANTE OMICS

Dante Genomics Expands into Dante Omics AI: Pioneering the Future of Precision Healthcare

NEW YORK--(BUSINESS WIRE)--Dante Genomics, a global leader in AI-driven genomic analysis, has expanded into Dante Omics AI to reflect its evolution into a multiomics platform. By integrating genomics, RNA, proteomics, and spatial transcriptomics under one advanced AI framework, Dante Omics AI offers a comprehensive view of human biology, accelerating breakthroughs for clinics, doctors, researchers and biopharma. The expansion into multiomics started in 2023, pushed by requests by users and cust...

Dante Omics Awarded Prestigious ISO 9001 Certification for Italian Laboratory

NEW YORK--(BUSINESS WIRE)--Dante Omics, a trailblazer in genomics-driven artificial intelligence solutions, is proud to announce that its cutting-edge laboratory in Italy has been awarded the internationally recognized ISO 9001:2015 certification for “Provision of genomic Next Generation Sequencing, analysis and interpretation services.” The ISO9001 certification was issued to Dante Labs Srl. This achievement marks a significant step in the company’s commitment to maintaining the highest standa...

Dante Labs achieves ISO 13485 certification for its Genomic Interpretation Software Immensa, leveraging an 18 month long clinical validation study of 500,000 samples

CAMBRIDGE, England--(BUSINESS WIRE)--Dante Labs achieves ISO 13485, leveraging an 18 month long clinical validation study of 500,000 samples....
Back to Newsroom